^
BIOMARKER:

TMB-L

i
Other names: TMB | Tumor Mutational Burden




Show legend

Include preclinical:
Non Small Cell Lung Cancer
Triple Negative Breast Cancer
Colorectal Cancer
Follicular Lymphoma
Melanoma
Mast Cell Leukemia
Adrenal Cortex Carcinoma
Glioblastoma
Pancreatic Cancer
Lung Cancer
Diffuse Large B Cell Lymphoma
Neuroendocrine Tumor
Lymphoma
Breast Cancer
Malignant Pleural Mesothelioma
Gastric Cancer
Pancreatic Ductal Adenocarcinoma
trametinib + dabrafenib + PDR001
rituximab
mitotane
anlotinib + APL-502
nivolumab + COM701
atezolizumab
durvalumab + tremelimumab
nivolumab + BMS-986227
avelumab + axitinib
ibrutinib
durvalumab
palbociclib + avelumab + axitinib
nivolumab + HS-110
bevacizumab
toripalimab-tpzi
olaparib
trametinib + Torin1
T-lymphocyte cell therapy
Immunotherapy
Tyrosine kinase inhibitor
PD1 inhibitor
PD-L1 inhibitor